Supernus Pharmaceuticals | SUPN - 销售收入

股票价格

51.53

每天变化

-0.75 -1.43%

每月一次

0.06%

每年

62.56%

Q2 预测

46.85

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 48.5M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.86B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	销售	更改		日
Abbott	USD 11.16B		300M	2026-03
ANI Pharmaceuticals	USD 237.5M		9.56M	2026-03
Aurora Cannabis	CAD 94.19M		3.82M	2025-12
Bristol-Myers Squibb	USD 11.49B		1.01B	2026-03
Canopy Growth	CAD 74.54M		7.86M	2025-12
Cara Therapeutics	USD 2.57M		1.11M	2025-03
Corcept Therapeutics	USD 164.9M		37.22M	2026-03
Eisai	JPY 219.94B		22.58B	2025-12
Eli Lilly	USD 19.8B		500M	2026-03
Novo Nordisk	DKK 96.82B		17.68B	2026-03
Pacira	USD 177M		19.87M	2026-03
Perrigo	USD 969M		141M	2026-03
Pfizer	USD 14.5B		3.08B	2026-03
Supernus Pharmaceuticals	USD 207.71M		3.89M	2026-03
United Therapeutics	USD 781.5M		8.7M	2026-03
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03